Ruijin Hospital
Shanghai, Shanghai Municipality, 200025, China
Location status: Recruiting
NCT Number: NCT04137549
Ambulatory blood pressure monitoring (ABPM) is a major innovation in the history of hypertension diagnosis. In clinical practice, the most well established indication for using ABPM is to identify patients who have high BP readings in the office but normal readings during usual daily activities outside of this setting or vice versa, and to identify varying 24-h BP profiles. However, in recent years, there has been increasing interest in BP values during sleep, and nocturnal BP is now recognized to be superior to daytime BP in predicting fatal and nonfatal cardiovascular events (stroke, myocardial infarction, and cardiovascular death), especially in medicated patients.
The current direction in the management of hypertension is toward earlier and lower BP control for 24 hours, including the nocturnal and morning periods. Therefore, it may be of great significance to pay attention to the management of nocturnal blood pressure so as to reduce the increased cardiovascular risks.
Information of nocturnal hypertensive patients defined by ABPM was prospectively registered nationwide, and then to investigate whether there was difference in cardiovascular prognosis according to the control of ambulatory nocturnal blood pressure.
Interested in participating?
Request Info50 year–79 year
All sexes
Observational
Shanghai, Shanghai Municipality, 200025, China
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From date of enrollment until date of first documented event assessed up to 3 years
Fatal and non-fatal cardiovascular events, including cardiovascular mortality, non-fatal myocardial infarction, non-fatal stroke, coronary artery bypass grafting or interventional stenting or balloon dilation, and hospitalization for heart failure.
Time frame: From date of enrollment until date of first documented event, assessed up to 3 years
Time frame: From date of enrollment until date of first documented event assessed up to 3 years
Contact information is provided by the study sponsor or research team.
Shanghai Institute of Hypertension
Other
Registry Study on "Control Nocturnal Hypertension to Reach the Target "(CONTROL-NHT)
Acronym: CONTROL-NHT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06780865
Chronic Disease, Chronic Kidney Disease(CKD)
View Trial DetailsNCT03050229
Diabetes Mellitus, Diabetes Mellitus, Type 2
Fukuoka, Japan
View Trial Details